Pregnancy- and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment?
نویسندگان
چکیده
BACKGROUND CONTEXT Pregnancy- and lactation-associated osteoporosis is an uncommon condition that may be a consequence of preexisting low bone density, loss of bone mineral content during pregnancy, and increased bone turnover. PURPOSE To present a case of severe osteoporosis associated with pregnancy and lactation and its treatment protocol. STUDY DESIGN/SETTING A tertiary care hospital. PATIENT SAMPLE A young female after twin pregnancy presenting with severe osteoporosis. METHODS The diagnosis was done on the basis of bone mineral density (BMD) measurement. The patient was treated with first alendronate and then strontium ranelate. She was considered as a candidate for kyphoplasty. RESULTS A dramatic increase in the BMD and palliation of back pain were observed. CONCLUSIONS Strontium ranelate may be a new alternative in the treatment of pregnancy- and lactation-associated osteoporosis.
منابع مشابه
Cardiac concerns associated with strontium ranelate
INTRODUCTION Strontium ranelate is proven to reduce vertebral and non-vertebral fracture risk in osteoporosis. Concerns about cardiac safety have led to a new contraindication to strontium ranelate in patients with uncontrolled hypertension and/or current or past history of ischaemic heart disease, peripheral arterial disease and/or cerebrovascular disease. AREAS COVERED A literature search w...
متن کاملStrontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
OBJECTIVES Early osteoporotic fractures have a great impact on disease progression, the first fracture being a major risk factor for further fractures. Strontium ranelate efficacy against vertebral fractures is presently assessed in a subset of women aged 50-65 years. METHODS The Spinal Osteoporosis Therapeutic Intervention (SOTI) was an international, double blind, placebo controlled trial, ...
متن کاملStrontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
Osteoporosis is a progressive and debilitating disease characterized by a massive bone loss with a deterioration of bone tissues, and a propensity for a fragility fracture. Strontium ranelate is the first antiosteoporotic treatment that has dual mode of action and simultaneously increases bone formation, while decreasing bone resorption, thus rebalancing bone turnover formation. Strontium ranel...
متن کامل[The efficacy of strontium ranelate (Osseor) on fractures in osteoporosis].
The clinical experiences with strontium ranelate (Osseor) in osteoporosis treatment are presented. Strontium ranelate (Osseor) has proven efficacy at the vertebral and nonvertebral levels including patients with osteopenia and osteoporosis regardless of patients age.
متن کاملStrontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy
Strontium ranelate is a new orally administered agent for the treatment of women with postmenopausal osteoporosis that reduces the risk of vertebral and hip fractures. Evidence for the safety and efficacy of strontium ranelate comes from two large multinational trials, the SOTI (Spinal Osteoporosis Therapeutic Intervention) and TROPOS (Treatment Of Postmenopausal Osteoporosis) studies. The SOTI...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The spine journal : official journal of the North American Spine Society
دوره 9 4 شماره
صفحات -
تاریخ انتشار 2009